Tauriga Sciences, Inc. Expands its Presence to Gas Stations and Convenience Stores on a National Level
The Company will Showcase its Product Lines to the Largest National Distributors that Service the Convenience Store & Petroleum Retailing Industries
NEW YORK, NY, Feb. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it has expanded its presence and reach to gas stations and convenience stores on a National level. This important business objective has been achieved through a Principal Partner Sponsorship Program (“Sponsorship”) with CSP Magazine (“CSP”); the leading convenience store and petroleum retailing publication. CSP ranks # 1 in readership and market share over all other industry publications, with a highly targeted circulation to more than 100,000 subscribers (mainly comprised of: convenience store operators, petroleum retailers, distributors, and suppliers).
Under terms of this Sponsorship, Tauriga will be a major participant at the upcoming “CBD West – CBD & Convenience Retail Conference” in Denver, Colorado on April 14-16, 2020 - The venue will be The Curtis Hotel.
Principal Partner Sponsorship benefits include:
1. Company Logo on the Conference materials & recognition from podium.
2. Assigned seating each day with retailers and other sponsors
3. Tabletop display of Products and Promotional Materials during the length of the Conference
4. Participation in Speed Insights Session with 12-15 selected Retailers. Product display and sampling is permitted within Speed Insights Session/Suite Meetings.
5. 1 on 1 meetings with the large national distributors and convenience store operators & retailers.
Additionally, the Company will be a major Participant at the “CBD-East – CBD & Convenience Retail Conference” in Jacksonville, Florida – November 2020.
CSP Magazine (“CSP”) is the leading source of information for the $600 billion convenience-retailing industry. Its award-winning editors provide actionable solutions and data-driven trends to key decision-makers who rely on this information to combat disruption. CSP annually hosts and the conference, which are two large-scale leadership events, as well as 15 small-format meetings in its EduNetworking series.
For more than 20 years, CSP magazine has dominated the convenience channel and has become the industry’s most respected publication. Whether in our print or digital products, or at one of our 15 meetings and conferences, CSP delivers the emerging trends and solutions-based data readers need to help them stay successful and relevant in an era of constant disruption.
CSP ranks # 1 in readership and market share over all other industry publications. Our highly targeted circulation to more than 100,000 subscribers helps our clients share their message with key decision-makers and business leaders 15 times a year.
Website Link:
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-Gum™. The Company is currently in production of three distinct flavors of Tauri-Gum™: MINT, BLOOD ORANGE, and POMEGRANATE. On December 6, 2019 the Company announced that it completed the initial production run (thereby expanding its existing product lines) with the introduction of a 25mg Vegan CBD Isolate Infused vegan gummy (“gumdrop”), branded under the name: Tauri-Gummies™. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at .
The Company has also announced the development of a Cannabigerol (“CBG”) Isolate infused version of Tauri-Gum™. The flavor that has been selected is Starfruit/Peach and each piece of gum will contain 10mg of CBG Isolate / Each blister pack will contain 80mg of CBG Isolate. The Company expects to commence production during its 4th Fiscal Quarter of 2020 (January 1, 2020 – March 31, 2020).
In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site - as part of its Tauri-Gum™ commercialization strategy. This site can be accessed by visiting the following URL address:
The Company has established corporate offices in both New York City (USA) and Barcelona (Spain).
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.
Attachment
CONTACT INFORMATION Tauriga Sciences, Inc. 555 Madison Avenue, 5th Floor New York, NY 10022 Chief Executive Officer Mr. Seth M. Shaw Email: cell # (917) 796 9926 Corp. Website: E-Commerce Website:
